IB ACQUISITION CORP.

IBAC ·Healthcare, Diagnostics & Research, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Jun 2024 Mar 2024 Dec 2023
Operating Activities
Net Income $1.1M $-194.6K $-87.5K
Depreciation & Amortization
Depreciation
Amortization
Stock-Based Compensation
Net Cash from Operating Activities $-585.2K $-103.8K $-78.0K
Investing Activities
Capital Expenditures
Business Acquisitions
Net Cash from Investing Activities
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $-199.4K $117.2M $205.1K
Net Change in Cash
Free Cash Flow
← Newer Page 2 of 2 Older →